THE PERIPHERAL BLOOD LEUKOCYTE PHENOTYPE IN PATIENTS WITH BREAST CANCER: EFFECT OF DOXORUBICIN/PACLITAXEL COMBINATION CHEMOTHERAPY

This publication has 26 references indexed in Scilit:

• Oligoclonality of CD8 + T cells in health and disease: Aging, infection, or immune regulation?
  Human Immunology, 1996
• CD69⁺ and HLA‐DR⁺ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: Correlations with survival following active specific immunotherapy
  International Journal of Cancer, 1995
• Modulation of suppressor cell activities by cyclophosphamide in breast cancer patients
  Journal of Clinical Laboratory Analysis, 1994
• Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen
  Breast Cancer Research and Treatment, 1994
• Reduced lymphocyte subpopulations in patients with advanced or disseminated melanoma
  Journal of the American Academy of Dermatology, 1993
• Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T-lymphocyte subset ratios during treatment for early-stage breast carcinoma
  Cancer, 1991
• Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients
  Cancer Immunology, Immunotherapy, 1991
• Biological response modifiers in the management of patients with breast cancer
  Breast Cancer Research and Treatment, 1990
• Analysis of T Helper and Suppressor Lymphocyte Subsets in Relation to the Clinical Stage of Solid Neoplasms
  Oncology, 1990
• Blood lymphocyte counts with subset analysis in operable breast cancer. Relation to the extent of tumor disease and prognosis
  Cancer, 1985